Evidence map›Paper›PMID 25849832›Full record

ArticleAIDS (London, England)2015

Incomplete immune reconstitution despite virologic suppression in HIV-1 infected children and adolescents.

Paul Krogstad, Kunjal Patel, Brad Karalius, Rohan Hazra, Mark J Abzug, James Oleske, George R Seage, Paige L Williams, William Borkowsky, Andrew Wiznia and 3 more

Registry-linked trialAbstract read
In one paragraph

Article in AIDS (London, England), 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT01418014 (Adolescent Master Protocol), which is not on this map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01418014 completednot on this map

Adolescent Master Protocol

TypeobservationalSponsorHarvard School of Public Health (HSPH)Ran2007 to 2021Enrolled678ConditionsHIV/AIDS
3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Article
  3. Evolution of CD4 T-Cell Count With Age in a Cohort of Young People Growing Up With Perinatally Acquired Human Immunodeficiency Virus.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2024
    Article
  4. Article
  5. Article
  6. Article
  7. Use and Outcomes of Antiretroviral Monotherapy and Treatment Interruption in Adolescents With Perinatal HIV Infection in Asia.The Journal of adolescent health : official publication of the Society for Adolescent Medicine · 2019
    Observational
  8. Article
  9. Article
  10. Article
  11. Article
  12. Observational
  13. Article
  14. Targeting 90-90-90--don't leave children and adolescents behind.Journal of the International AIDS Society · 2015
    Article
  15. Getting to 90-90-90 in paediatric HIV: What is needed?Journal of the International AIDS Society · 2015
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 6 institutions in 3 countries.

Paul KrogstadaDepartment of Pediatrics (Infectious Diseases) bDepartment of Molecular and Medical Pharmacology, David Geffen School of Medicine at UCLA, University of California, Los Angeles, California cDepartment of Epidemiology, Center for Biostatistics in AIDS Research (CBAR), Harvard School of Public Health, Boston, Massachusetts dEunice Kennedy Shriver National Institute of Child Health & Human Development, Bethesda, Maryland eUniversity of Colorado School of Medicine and Children's Hospital Colorado, Aurora, Colorado fDepartment of Pediatrics, Rutgers New Jersey Medical School, Newark, New Jersey gNew York University School of Medicine hAlbert Einstein College of Medicine, New York City, New York, USA iDepartment of Pediatrics, Federal University of Minas Gerais, Minas Gerais, Brazil jTulane University School of Medicine, New Orleans, Louisiana, USA.
Kunjal Patel
Brad Karalius
Rohan Hazra
Mark J Abzug
James Oleske
George R Seage
Paige L Williams
William Borkowsky
Andrew Wiznia
Jorge Pinto
Russell B Van Dyke
Pediatric HIVAIDS Cohort Study, IMPAACT 219C, and NICHD International Site Development Initiative (NISDI) Investigators
Apple (Israel) · ILBlack AIDS Institute · USChildren's Hospital Colorado · USNew York University · USRutgers, The State University of New Jersey · USUniversidade Federal de Minas Gerais · BR

Funding

PHACS - Data and Operations CenterU01HD052102 · NICHD · HARVARD UNIVERSITY (SCH OF PUBLIC HLTH) · PI WILLIAMS, PAIGE L · 2005 to 2019
$242.7M
Statistical and Data Management Center-Pediatric,Adolescent, and Maternal CTGUM1AI068616 · NIAID · HARVARD UNIVERSITY D/B/A HARVARD SCHOOL OF PUBLIC HEALTH · PI Sean Scott Brummel, Marlene Ann Cooper · 2011 to 2026
$155.6M
Colorado Clinical and Translational Sciences InstituteUL1TR001082 · NCATS · UNIVERSITY OF COLORADO DENVER · PI SOKOL, RONALD J. · 2013 to 2017
$48.0M
Statistical and Data Management Center-Pediatric,Adolescent, and Maternal CTGU01AI068616 · NIAID · HARVARD SCHOOL OF PUBLIC HEALTH · PI SHAPIRO, DAVID ERIC · 2006 to 2010
$38.6M
Pediatric HIV/AIDS Cohort Study (PHACS): Understanding Maternal HIV Disease through Pregnancy and the Postpartum Period and its Role in Child Health OutcomesU01HD052104 · NICHD · TULANE UNIVERSITY OF LOUISIANA · PI VAN DYKE, RUSSELL B. · 2005 to 2019
$15.7M
NICHD INTERNATIONAL PEDIATRIC AND PERINATAL HIV STUDIES NETWORK COORDI-275033345N01HD033345 · NICHD · WESTAT · PI NESEL, CAROL · 2004 to 2006
–
NCATS NIH HHS UL1 TR001082NIAID NIH HHS U01 AI068616NIAID NIH HHS UM1 AI068616NICHD NIH HHS HD052102NICHD NIH HHS HD052104NICHD NIH HHS N01 HD033345NICHD NIH HHS U01 HD052102NICHD NIH HHS U01 HD052104NIDDK NIH HHS HHSN267200800001C
6 · The paper itself

Abstract

objectivesSome perinatally infected children do not regain normal CD4(+) T-cell counts despite suppression of HIV-1 plasma viremia by antiretroviral therapy (ART). The frequency, severity and significance of these discordant treatment responses remain unclear.

designWe examined the persistence of CD4(+) lymphocytopenia despite virologic suppression in 933 children (≥ 5 years of age) in the USA, Latin America and the Caribbean.

methodsCD4(+) T-cell trajectories were examined and Kaplan-Meier methods used to estimate median time to CD4(+) T-cell count at least 500 cells/μl.

resultsAfter 1 year of virologic suppression, most (99%) children achieved a CD4(+) T-cell count of at least 200 cells/μl, but CD4(+) T-cell counts remained below 500 cells/μl after 1 and 2 years of virologic suppression in 14 and 8% of children, respectively. Median times to first CD4(+) T-cell count at least 500 cells/μl were 1.29, 0.78 and 0.46 years for children with less than 200, 200-349 and 350-499 cells/μl at the start of virologic suppression. New AIDS-defining events occurred in nine children, including four in the first 6 months of virologic suppression. Other infectious and HIV-related diagnoses occurred more frequently and across a wide range of CD4(+) cell counts.

conclusionART improved CD4(+) cell counts in most children, but the time to CD4(+) cell count of at least 500 cells was highly dependent upon baseline immunological status. Some children did not reach a CD4(+) T-cell count of 500 cells/μl despite 2 years of virologic suppression. AIDS-defining events occurred in 1% of the population, including children in whom virologic suppression and improved CD4(+) T-cell counts were achieved.

Indexed as

Viral LoadAdolescentAnti-Retroviral AgentsCaribbean RegionCD4 Lymphocyte CountCD4-Positive T-LymphocytesChildChild, PreschoolCohort StudiesFemaleHIV-1HIV InfectionsHumansLatin AmericaLymphopeniaMaleAnti-Retroviral Agents

Identifiers

PMID25849832
PMCPMC4391276
OpenAlexW2054480633

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.